Damonapharma
4 employees on LinkedIn · 4 known investors
Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia. Its lead drug targets a specific subunit of the GABA-A receptor to improve neuronal function and reverse cognitive impairment.
Investors · 4
Competitors · 5
by search overlap
Day One Biopharmaceuticals7 shared keywordsDay One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
Bioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Muna Therapeutics5 shared keywordsMuna Therapeutics is a biotechnology company that discovers and develops therapies aimed at slowing or stopping neurodegenerative diseases, including Alzheimer's and Parkinson's. It operates in neurology-focused drug discovery and development.
Inspirna4 shared keywordsInspirna is a clinical-stage biopharmaceutical company developing first-in-class cancer therapeutics, including oral small molecules and biologics that target newly discovered drivers of metastasis in common cancers such as colorectal, non-small cell lung, and endometrial cancer. It uses its proprietary RNA-DRIVEr platform and microRNA mapping to identify cancer drivers for patients with high unmet medical needs.
Moderna4 shared keywordsModerna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
Companies competing with Damonapharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Damonapharma do?
- Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia. Its lead drug targets a specific subunit of the GABA-A receptor to improve neuronal function and reverse cognitive impairment.
- Who are Damonapharma's investors?
- Damonapharma's investors include Angelini Ventures, Lumira Ventures, Noetic, Toronto Innovation Acceleration Partners.